Abstract

Objective. To investigate effects and possible mechanisms of transcutaneous electrical acustimulation (TEA) performed by a wearable watch-size stimulator for refractory gastroesophageal reflux disease (RGERD). Methods. Twenty patients diagnosed as RGERD were enrolled in the study and randomly divided into four groups: esomeprazole group (Group A), esomeprazole combined with TEA group (Group B), esomeprazole combined with sham-TEA group (Group C), and esomeprazole combined with domperidone group (Group D). HRM and 24 h pH-impedance monitoring and GerdQ score were used to measure related indexes before and after treatment. Results. (1) TEA significantly increased LESP, compared with PPI treatment only or PPI plus sham-TEA. After pairwise comparison, LESP of Group B was increased more than Group A (P = 0.008) or Group C (P = 0.021). (2) PPI plus TEA decreased not only the number of acid reflux episodes but also the number of weak acid reflux episodes (P = 0.005). (3) Heartburn and reflux symptoms were improved more with PPI + TEA than with PPI treatment only or PPI plus sham-TEA (GerdQ scores, P = 0.001). Conclusion. TEA can improve symptoms in RGERD patients by increasing LESP and decreasing events of weak acid reflux and acid reflux; addition of TEA to esomeprazole significantly enhances the effect of TEA.

Highlights

  • Gastroesophageal reflux disease (GERD) is defined as a condition that appears when the reflux of stomach contents causes troublesome symptoms and/or complications

  • Doubling proton pump inhibitors (PPIs) dose represents the mainstay of treatment for refractory gastroesophageal reflux disease” (RGERD) [2]

  • We found that transcutaneous electrical acustimulation (TEA) significantly increased LESP and reduced weak acidreflux

Read more

Summary

Introduction

Gastroesophageal reflux disease (GERD) is defined as a condition that appears when the reflux of stomach contents causes troublesome symptoms and/or complications. Transoral incisionless fundoplication (TIF) and Stretta are emerging endoscopic therapies with minimal side-effects [3,4,5,6]. Another recent method, LES electrical stimulation therapy (LES-EST), which uses an implanted stimulation system is showing some unique advantages, especially for those with ineffective esophageal motility or aperistalsis or those who are unable to undergo traditional antireflux surgery. LES electrical stimulation therapy (LES-EST), which uses an implanted stimulation system is showing some unique advantages, especially for those with ineffective esophageal motility or aperistalsis or those who are unable to undergo traditional antireflux surgery These promising therapies are all invasive and their long-term efficacy and safety need further evaluation

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call